Press release

ETH Zurich: "Research, promotion and reform"

The energy revolution can be achieved: this was the general tenor of the ETH Zurich Climate Roundtable held on Wednesday. However, this will require new technologies and innovation must be promoted accordingly. But the form that state regulatory intervention should take was the subject of controversial debate.

Cambridge Epigenetix raises $5.5M in Series A funding

Cambridge Epigenetix (CEGX), a UK-based life sciences company, has announced the recent completion of a $5.5M Series A financing round led by New Science Ventures and the appointment of Dr Fedja Bobanovic as CEO. Joining the financing round were founding investors Syncona Partners and Cambridge Enterprise.